vimarsana.com

Page 5 - ஆஂடேரியொ நிறுவனம் க்கு புற்றுநோய் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Portage BioTech Inc : Portage Biotech Highlights Initiation of the Invincible Trial, a Phase 2 Early Stage Breast Cancer Study from Intensity Therapeutics

Portage BioTech Inc : Portage Biotech Highlights Initiation of the Invincible Trial, a Phase 2 Early Stage Breast Cancer Study from Intensity Therapeutics
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Portage Biotech Highlights Initiation of the Invincible Trial, a Phase 2 Early Stage Breast Cancer Study from Intensity Therapeutics

Portage Biotech Highlights Initiation of the Invincible Trial, a Phase 2 Early Stage Breast Cancer Study from Intensity Therapeutics
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.

CPDC Announces Appointment of Bruno Paquin as Permanent CEO

CPDC Announces Appointment of Bruno Paquin as Permanent CEO News provided by Share this article Share this article HAMILTON, ON, March 10, 2021 /PRNewswire/ - The Centre for Probe Development and Commercialization (CPDC) announced that its Board of Directors has appointed Bruno Paquin as Chief Executive Officer (CEO). The CEO appointment has taken effect on March 4, 2021.  Dr. John Thornback, Chair of the Board of Directors said, W e are pleased to announce that Bruno Paquin has been appointed CEO of CPDC with immediate effect. The Board feels that Bruno has done an excellent job as interim CEO over the past few months and we are looking forward to working with Bruno, and everyone in the CPDC family, our clients and employees, as he leads us through the next phases of development to a successful future.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.